We don't have a lot of price history, but what we do see is bullish for DOCS.
The technical signs of the provider of senior housing are mixed at present.
These picks are attractive for value-oriented dividend investors looking for strong current income potential.
The shares are only trading at 17 times forward earnings, and might not be fully valued just yet.
The charts of the vaccine maker indicate it's a good time to take some profits or raise stops, or both.
A subscriber asks. We answer.
Charts suggest there could be further downside risk.
Here's how the U.S. can play a critical part in defending the island from COVID -- and mainland China.
Traders could go long PFE at current levels and here's where they can add to longs.
Avoid the long side of GDRX until we see evidence of a durable bottom.